Latest healthcare news

An article published in The Lancet by Toback and others on November 17, 2021 discusses  this issue.  The safety and immunogenicity profile of COVID-19 vaccines when administered  concomitantly with seasonal influenza vaccines has not yet been reported....

An interesting report published by Sima in the Scientific American showed that a cheap, widely available drug use to treat mental illness cut both the risk of death from COVID-19 and the need for people with the disease to receive intensive medical care.  The...

Pfizer’s COVID pill will cut the risk of hospital admission and virus deaths.   The science editor of the Times, Tom Whipple published a review of this.   He suggests that the new antiviral pill will slash the risk of hospital admission and death...

An interesting article published by Cromer and others in The Lancet, November 15 discusses  this issue.   Several SARS-CoV-2 variants of concern have been identified which partly escape serum  neutralisation elicited by the current...

The Shingrix vaccine, shingles vaccine appears to give benefit and help to reduce the risk of COVID-19 in older adults. An interesting preprint published in medRxiv by Bruxvoort and others suggests that vaccines may elicit long term boosting of innate immune responses...

A personal view published by Milne and others in The Lancet Respiratory Medicine October 21st 2021, looks at this.  It is further discussed by Altmann and others in a comment published October 21st 2021.  Many nations are pursuing the rollout of SARS-CoV-2...

An interesting correspondence in The Lancet rheumatology published by Sciascia October 20th 2021 discusses this issue.   Vaccines represent a cornerstone in controlling the COVID-19 pandemic.  The availability of data on the immunogenicity and...

An interesting letter published in the New England Journal of Medicine by Courtney Temple and others October 20th 2021 highlights this issue.  Ivermectin is approved by the FDA as an oral treatment for intestinal strongyloidiasis and onchocerciasis and is a...

A paper from America published by the CDC shows that people who have received a vaccine booster are reporting side effects which are similar to those after the second dose.  The report relies on more than 12,500 submissions via V-safe, the CDC smartphone based...

An interesting paper published on 9th September 2021, in Nature Human Behaviour by Yang and others looked at the effect of remote working on collaboration amongst information workers.   The COVID-19 pandemic caused a rapid shift to full time remote work for...

An interesting comment by Sandmann published on September 22nd 2021 in Lancet Infectious Diseases considers the vaccination rollout in Israel. In The Lancet Infectious Diseases, Eric Haas and colleagues estimated the benefits of the rapid mass roll-out of the Pfizer...

A comment article published by Monti and others in The Lancet September 19th argues that to build a post-pandemic future, in which everyone's health is protected and promoted, we must learn from the events of the COVID-19 pandemic and previous crises. The Pan-European...